NASDAQ: SNYSanofi Stock
$52.74-0.12 (-0.23%)
Updated Jan 28, 2022
SNY Price
$52.74
Fair Value Price
N/A
Market Cap
$132.99B
52 Week Low
$45.17
52 Week High
$54.26
P/E
19.36x
P/B
1.79x
P/S
2.95x
PEG
0.89x
Dividend Yield
3.61%
Revenue
$44.17B
Earnings
$6.92B
Gross Margin
67.6%
Operating Margin
20.48%
Profit Margin
15.5%
Debt to Equity
0.77
Operating Cash Flow
$10B
Beta
0.59
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
High
Medium
Low
–
Industry Average (42)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SNY ($52.74) is trading below its intrinsic value of $232.01, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
SNY is good value based on its earnings relative to its share price (19.36x), compared to the US market average 33.7x)
Valuation
SNY is good value based... subscribe to Premium to read more.
Valuation
There are 34 more SNY due diligence checks available for Premium users.
SNY News
Valuation
SNY fair value
Fair Value of SNY stock based on Discounted Cash Flow (DCF)
Price
$52.74
Fair Value
$56.73
Undervalued by
7.04%
SNY ($52.74) is trading below... subscribe to Premium to read more.
Valuation
SNY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
19.36x
Industry
25.74x
Market
33.7x
SNY is good value based... subscribe to Premium to read more.
Valuation
SNY is good value based... subscribe to Premium to read more.
Valuation
SNY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.79x
Industry
5.12x
SNY is good value based... subscribe to Premium to read more.
Valuation
SNY price to earnings growth (PEG)
For valuing profitable companies with growth potential
SNY is good value based... subscribe to Premium to read more.
Valuation
SNY's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SNY's Earnings (EBIT) of $9.05B... subscribe to Premium to read more.
Financials
SNY's profit margin has decreased... subscribe to Premium to read more.
Financials
Assets to liabilities
Assets
$133.7B
Liabilities
$58.3B
Debt to equity
0.77
SNY's short-term assets ($34.71B) exceed... subscribe to Premium to read more.
Financials
SNY's long-term liabilities ($35.09B) exceed... subscribe to Premium to read more.
Financials
SNY's debt relative to shareholder... subscribe to Premium to read more.
Financials
SNY's debt to equity ratio... subscribe to Premium to read more.
Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
SNY's operating cash flow ($9.74B)... subscribe to Premium to read more.
Financials
Sanofi Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.